Price trends of reimbursed oncological drugs in Switzerland in 2005-2019: A descriptive analysis.

Increasing oncological treatment costs are a major global concern with the risk of entailing two-tiered health care. Among cost determining factors is the price of individual drugs. In recognition of the central role of this factor, we present a comprehensive overview of the development of monthly p...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yael Rachamin, Christoph Jakob Ackermann, Oliver Senn, Thomas Grischott
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/7cceb14eaa2541c6b333e1e614f3fbb9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Search Result 1